CEO Steve Lydeamore To Present
CEO Steve Lydeamore To Present
Sydney, Nov 18, 2019 AEST (ABN Newswire) - Anatara Lifsciences Ltd (ASX:ANR) CEO Steve Lydeamore has been invited to present at the Pitt Street Research Life Sciences Conference on the 28th November in Sydney. Any investors interested in attending these presentations are invited to reach out.

Details and registration links are summarised below:

Pitt Street Research Life Sciences Conference

This is a unique opportunity to meet some of the leading ASX-listed Biotechnology companies that focus on AgBiotech and Veterinary Biotech, with keynote speaker, Rick Holliday-Smith, Chairman of the Australian Securities Exchange (ASX:ASX), Cochlear (ASX:COH) and QBiotics, as well as Director of Servcorp (ASX:SRV).

Steve will provide an update on Anatara's work in gastrointestinal health for both humans and animals.

- Thursday 28th November 2019
- 8.45am until 1pm AEDST
- Baker McKenzie, Tower One - International Towers Sydney, Level 46, 100 Barangaroo Avenue, Sydney

Register to attend: contact Hayley van der Meer at hvandermeer@anatara.com.


About Anatara Lifesciences Ltd

Anatara Lifesciences ASX ANRAnatara Lifesciences (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing products for animal and human health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. For more information, please visit www.anataralifesciences.com.

    


Contact

Investor and Media inquiries

Steven Lydeamore
Chief Executive Officer
Anatara Lifesciences Ltd
T: +61-438-027-172
E: slydeamore@anatara.com

Sue MacLeman
Chair
Anatara Lifesciences Ltd
T: +61-437-211-200
E: smacleman@anatara.com


Related Companies

Servcorp Limited       
Cochlear Limited        
Anatara Lifesciences Ltd

ABN Newswire This Page Viewed:  (Last 7 Days: 83) (Last 30 Days: 1139)